ALPHA TAU MEDICAL LTD

Alpha Tau CFO sells shares amid 40% monthly jump; insider sale at $10.80 reflects confidence in Tolmar partnership, Alpha DaRT® launch and bullish outlook.

Alpha Tau Medical’s insider activity signals strong confidence in its alpha‑radiation oncology platform, revealing growth prospects and potential dilution risks for investors.